Zehnder Group AG (0R6S)
London Exchange · UK · prices in GBP · close of 22 Oct 2026
Key indicators
| Last close | GBP 70.80 |
|---|---|
| 52-week range | 59.80 – 91.98 |
| Return, 1 month / 3 months | −3.3% / +13.9% |
| Return, 1 year / 3 years | +0.7% / +32.7% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 30.3% |
| Worst drawdown (1 year) | -33.8% |
| Average daily value traded | 0.25M GBP |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zehnder Group makes heating, cooling and ventilation products for buildings. Its range includes radiators, heat exchangers, and ventilation systems for homes and commercial premises, sold under brands such as Zehnder and Runtal. Customers are mainly building owners, installers, architects and property developers who need indoor climate and air-quality solutions. The company is based in Switzerland and supplies markets across Europe and beyond.
Zehnder Group AG trades under the code 0R6S on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zehnder Group AG (0R6S) trades on the London Exchange in UK. It last closed at GBP 70.80 on 22 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 2,140 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.7% and over the last three months it rose 13.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 46 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -0.8% | ||
| From 52-week high | -21.7% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.9% | ||
| 6-month return | 7.3% | ||
| 12-month return, skipping the last month | 4.1% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.8% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.25M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | 25 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.7% |
|---|---|
| 1 month | −3.3% |
| 3 months | +13.9% |
| 6 months | +7.3% |
| 1 year | +0.7% |
| 3 years | +32.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 71.83 / 71.37 |
|---|---|
| Golden / death cross (60 days) | Golden, 4 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.65 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Mar 2026 | GBX 0.0140 |
| 7 Apr 2025 | GBX 0.0100 |
| 15 Apr 2024 | GBX 0.0130 |
| 27 Mar 2023 | GBX 0.0180 |
| 11 Apr 2022 | GBX 0.0180 |
| 30 Mar 2021 | GBX 0.0125 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.